Stockscreener 앱 받기
21.48
0.00%
0.00
전일 마감가:
$21.48
열려 있는:
$21.52
하루 거래량:
1.04M
Relative Volume:
0.35
시가총액:
$2.11B
수익:
$221.08M
순이익/손실:
$-2.92M
주가수익비율:
-650.91
EPS:
-0.033
순현금흐름:
$5.89M
1주 성능:
-0.09%
1개월 성능:
+0.51%
6개월 성능:
+101.69%
1년 성능:
+168.50%
1일 변동 폭
$21.48
$21.54
1주일 범위
$21.45
$21.60
52주 변동 폭
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
명칭
Avadel Pharmaceuticals Plc
전화
636-449-1830
주소
10 EARLSFORT TERRACE, DUBLIN 2
AVDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.48 | 2.11B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | 개시 | Wells Fargo | Equal Weight |
| 2025-07-18 | 재개 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-06-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-05 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-05 | 재확인 | Needham | Buy |
| 2024-03-05 | 재확인 | Oppenheimer | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2022-11-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-28 | 재개 | Craig Hallum | Buy |
| 2022-05-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-07-21 | 개시 | SVB Leerink | Outperform |
| 2020-06-30 | 개시 | H.C. Wainwright | Buy |
| 2020-04-03 | 개시 | Jefferies | Buy |
| 2020-03-12 | 개시 | Stifel | Buy |
| 2020-02-26 | 개시 | Piper Sandler | Overweight |
| 2020-01-30 | 개시 | Craig Hallum | Buy |
| 2019-06-14 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
모두보기
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Form 8.3 - GlobeNewswire Inc.
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.32% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals
Sentiment Review: Can Annovis Bio Inc disrupt its industryBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. $AVDL Position Decreased by Wealth Effects LLC - MarketBeat
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com India
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com India
Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings - Investing.com India
FIL Limited discloses 3.14% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs Asset Management reduces stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals - Investing.com
FIL Limited discloses 3.14% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.23% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Rechecking Avadel Pharmaceuticals (AVDL) Valuation After Strong Share Price Momentum - Yahoo Finance
Aug Update: Should I hold or sell Avadel Pharmaceuticals plc stock in 2025Market Movement Recap & Capital Protection Trading Alerts - Bộ Nội Vụ
Avadel Shareholders Approve Acquisition by Alkermes - Sleep Review
Bank of America discloses 1.23% stake in Avadel Pharmaceuticals - Investing.com
Avadel shareholders approve acquisition by Alkermes - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals - Investing.com
FMR LLC and FIL Limited disclose 3.06% stake in Avadel Pharmaceuticals - Investing.com Nigeria
Alkermes (ALKS) Secures Shareholder Approval for Avadel Acquisition - GuruFocus
Avadel Shareholders Approve Acquisition by Alkermes plc - TipRanks
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes - The Manila Times
Avadel Pharmaceuticals plc Approves Scheme of Arrangement for Alkermes Acquisition - Quiver Quantitative
Shareholders back Avadel sale to Alkermes after strong vote - Stock Titan
Do options traders know something about Avadel Pharmaceuticals stock we don't? - MSN
BlackRock discloses 6.74% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Analyst Calls: Is Avadel Pharmaceuticals plc showing insider buying2025 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
BlackRock discloses 6.74% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals Plc (AVDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
1.45%
자본화:
|
볼륨(24시간):